Find and Buy Premium Documents by GlobalData

DocStore » GlobalData

Per Page: 15 25 50

«1...

1300 Smiles Limited (ONT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

1300 Smiles Limited (1300 Smiles) is a dental service company based in Australia. The company provides dentistry services to patients that include dental surgeries, practice management and other services to self-employed dentists who conduct their own dental practices. The company markets, administers, bills, collects, certifies facilities and licenses all participating dentists. The company owns and operates 24 multi-dentist facilities located in Cairns, Townsville, Mackay, Rockhampton, Gladstone, Bundaberg, Sunshine Coast (Caloundra), Brisbane (several different sites), Gold Coast (Tweed Heads) and Toowoomba. 1300 Smiles is headquartered in Townsville, Queensland, Australia.
Lundbeck Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Lundbeck Inc. (Lundbeck), formerly Ovation Pharmaceuticals, Inc., is a provider and developer of innovative specialty therapies. The company caters to patients suffering from central nervous system (CNS) disorders and rare diseases. The company is a wholly-owned subsidiary of H. Lundbeck A/S, one of the world's leading pharmaceutical companies committed to the development of treatment for brain disorders. The products it offers are broadly classified into three categories, namely, CNS, Hematology/Oncology and Hospital-based products.
Dicerna Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Dicerna Pharmaceuticals, Inc. (Dicerna) is a biopharmaceutical company based in the US. The company develops therapeutic agents and related drug delivery systems in multiple disease fields. Its products are based on its proprietary dicer substrate technology and dicer substrate RNA (DsiRNA) molecules. The technology of the company, Dicer Substrate Technology triggers RNA interference (RNAi) in a potent and specific manner. It is collaborated with Ipsen to develop novel conjugates of DsiRNA molecules and Ipsen’s peptide targeting vectors in the therapeutic fields such as, oncology and endocrinology. The company is also partnered with Kyowa Hakko Kirin. Dicerna is headquartered in Watertown, Massachusetts, the US.
Provexis plc (PXS) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Provexis plc is engaged in the development of functional food, medical food, and dietary supplement technologies. The company also offers licensing services to functional food, medical food, and dietary supplement technologies. Provexis is headquartered in the UK.
InDex Pharmaceuticals AB - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

InDex Pharmaceuticals AB (Index) is a Sweden based, immunology focused biopharmaceutical company. The company has developed two products based on its in-house, proprietary technology platform. The products include Kappaproct, which is being developed in Phase III clinical trials for the treatment of steroid resistant ulcerative colitis; and DIMS 9054, a preclinical potential treatment for steroid resistant asthma. It develops DNA-based immunomodulatory sequences (DIMS), which have IP protection in Europe. It also focuses on personalized medicine. In Sweden, InDex developed and launched DiBiCol, the diagnostic test for the discrimination between ulcerative colitis and Crohn's disease. InDex is headquartered in Stockholm, Sweden.
The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

The Children's Hospital of Philadelphia (CHOP) is a healthcare company, based in the US. The company provides pediatric healthcare solutions. Its service line includes fetal diagnosis and treatment, cardiac center, oncology, transplant center, neonatology and nursing. CHOP conducts many community services such as community asthma preventing program, poison control center, the center for child protection and health. Its pediatric research program has been ranked second in National Institutes of Health funding. The company has entered into a partnership agreement with BGI. It has more than 150 years of experience of serving patients and their families. CHOP is headquartered in Philadelphia, Pennsylvania, the US.
Nanobiotix - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Nanobiotix is a France-based, cancer-focused nanomedicine company. It undertakes the development of nanomedicine cancer treatments. The company focuses on developing NanoXray, a revolutionary therapeutic approach to local cancer treatment. The NanoXray technology consists of three products that have the ability to cause a fundamental change in cancer therapy and help overcome the current constraints in local cancer treatment. NanoXray nanoparticles augment the dose and potency of radiotherapy inside a tumor without increase in resultant damage to surrounding healthy tissues. The products include NBTXR3, NBTX-IV and NBTX-TOPO that help improve anti-cancer treatments for patients with solid tumors currently under radiotherapy. The company is also developing other nanomedicine programs including nanoMag, magnetic particles for the treatment and diagnosis of cancer; and nanoPDT, laser activated nanoparticles for cancer treatment. Nanobiotix is a part of Sonodrugs European consortium. Nanobiotix is headquartered in Paris, France.
Sanford Health - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Sanford Health is a pharmaceutical healthcare service provider, based in the US. The company operates a network of hospitals, clinics, and managed care, long-term care, and living facilities, to deliver healthcare services. Its services include abdominoplasty, acute care, aging, air transport, allergies, asthma, athletic health, athletic performance, audiology, backpain, bariatric surgery, blood disorders, breast and bone health institute, cancer care and services, cardiac rehabilitation, cardiac surgery and child services. The company was formerly known as Sioux Valley Hospitals and Health System. Sanford Health is headquartered in Sioux Falls, South Dakota, in the US.
Bayer Healthcare LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Bayer HealthCare, LLC is a division of Bayer AG. Bayer HealthCare LLC has a unit in U.S named as Bayer HealthCare Pharmaceuticals Inc, which is engaged in the Women’s Healthcare, Diagnostic Imaging, Specialized Therapeutics, Hematology/Cardiology and Oncology.
MabVax Therapeutics, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

MabVax Therapeutics, Inc. (MabVax) is a pharmaceutical and health care service provider, based in the US. The company discovers and develops immunotherapeutics. It develops and commercializes polyvalent vaccines and human monoclonal antibodies for the treatment of cancer. The company’s products are used for the treatment of sarcoma, neuroblastoma, melanoma, ovarian and small cell lung cancers. It has plans to create a pipeline of fully human monoclonal antibody products against each of the targeted antigens. The company’s lead human antibody candidate is undergoing preclinical evaluation for development against colon, pancreatic and breast cancers. MabVax is headquartered in San Diego, California, the US.
ChemDiv, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

ChemDiv, Inc. (ChemDiv, Inc.) is a contract research organization, based in the US. The company provides drug discovery and development services. Its services include clinical development, pre-clinical development, drug discovery and discovery tools, therapies discovery and development, and synthetic and medicinal chemistry research services. ChemDiv provides services in the areas of central nervous system, oncology, inflammation, metabolic, and infectious diseases. The company offers screening libraries and solutions for compound acquisition and logistics support. It is partnered with Aviron Pharma and deCODE Biostructures. The company has its presence in North America, Eastern and Western Europe, Asia and Middle East. ChemDiv is headquartered in San Diego, California, the US.
Cognis GmbH - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Cognis GmbH (Cognis) is a chemical providing company, based in Germany. It operates through its segments Care Chemicals, Nutrition and Health, and Functional Products. The company supplies specialty chemicals and nutritional ingredients. It provides various products such as adhesives, agrosolutions, care chemicals, coatings, emulsion polymerization, graphic arts, industrial coatings, ion-transfer technology, mining chemicals, polymer building blocks and synlubes technology for a wide variety of industrial markets. Cognis serves food, beverage, dietary supplement and pharma industries. It serves its customers through 62 locations in over 30 countries across Asia-Pacific, Europe, and America regions. The company is owned by Permira, GS Capital Partners and SV Life Sciences. Cognis is headquartered in Dusseldorf, Germany.
Prospect Medical Holdings Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

Prospect Medical Holdings, Inc. (Prospect) is a healthcare services provider, based in the US. The company provides healthcare and physician services in Southern California and San Antonio, Texas. It offers medical, surgical and psychiatric services. The company owns and operates seven hospitals, with a total of about 1,056 licensed beds, and a network of 18 specialty and primary care clinics. It also manages the provision of physician services through medical groups that consist of physician networks of primary care and specialty physicians. The company’s medical groups provide physician services to more than 181,400 enrollees. Its hospitals include Alta Hospitals System, LLC, Brotman Medical Center, Nix Hospitals System, LLC, Prospect Medical Systems, and ProMed Health Care Administrators. Prospect is headquartered in Santa Ana, California, the US.
SymBio Pharmaceuticals Limited (4582) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

SymBio Pharmaceuticals Limited (SymBio) is biopharmaceutical company. It developms drug candidates to target the underserved medical needs in the therapeutic areas of autoimmune, oncology and hematology diseases. The company also develops drug delivery products like transdermal patch containing granisetron for the treatment of chemotherapy induced nausea or vomiting (CINV). It's product pipeline is in various phases of development, that includes SyB L-0501, used as an anticancer agent; SyB D-0701, which is used as an anti-emetic transdermal patch; SyB-0702, an anticancer substance composed of polyethylene glycol-conjugated zinc protoporphyrin (PEG-ZnPP); and SyB L-1101/SyB C-1101 (rigosertib) for the treatment of hematologic malignancies and solid tumors. SymBio is headquartered in Minato-ku, Tokyo, Japan.
Mithridion, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

$250.00

$250.00
From:GlobalData

Document Overview:

MITHRIDION, INC. (Mithridion) is a biopharmaceutical company, based in the US. The company develops therapeutics targeting central nervous system disorders such as Alzheimer’s disease and schizophrenia. Its products include MCD-386, MCD-386CR, MI-08-016/035, MCD-386/Glycopyrrolate Combination and MI-10-022 Series. Mithridion’s MCD-386CR is used in the treatment of cognition impairment and cognitive impairment in schizophrenia. The company’s MCD-386 Pharmacology, a selective M1 muscarinic agonist as its product candidate for the treatment of Alzheimer's disease and schizophrenia. It is FDA certified company. The company partners with various pharmaceutical and biotechnology companies. Mithridion is headquartered in Madison, Wisconsin, the US.